Navy selects Leidos for $82M medical study contract
Company to study warfighter performance and operational medicine
Leidos Holdings Inc., a Reston-based defense, aviation, information technology and biomedical research company, has been selected by Naval Medical Logistics Command to continue studying warfighter performance and operational medicine in support of the Naval Health Research Center.
Under a potential five-year, $82 million contract, Leidos will employ a data-driven research modeling approach to augment medical decision tools used by field medical personnel, logisticians and operational commanders. The company will also carry out medical research, development, testing, evaluation and surveillance activities to study warfighter performance under the indefinite-delivery/indefinite-quantity contract.
Through this effort, NMLC aims to help the Department of Defense personnel enhance rehabilitation approaches, warfighter resilience and mission readiness through the contract. Most of the work will be conducted at NHRC in San Diego.
Liz Porter, president of Leidos’ health group, says NHRC research will be backed by the company’s scientific and technical expertise. “We are proud to do our part to improve lives and ensure our military personnel can perform at the highest levels.”
NHRC was established to perform studies on military health, infectious diseases and operational readiness. The center also creates logistics, decision support and medical planning tools for the U.S. military.